image
Enzo Biochem, Inc. ENZ
Healthcare - Medical - Diagnostics & Research - NYSE - US
Watchlist
$ 1.04
0 %
$ 54.3 M
Market Cap
-5.47
P/E
INCOME STATEMENT
31.9 M REVENUE
2.72%
Growth Rates
1Year 2.72%
3Years -35.29%
5Years -17.03%
7Years -15.96%
10Years -10.43%
-9.82 M OPERATING INCOME
60.31%
Growth Rates
1Year 60.31%
3Years -25.86%
5Years -2.40%
7Years -18.09%
10Years 0.36%
-26.1 M NET INCOME
-128.54%
Growth Rates
1Year -128.54%
3Years -62.76%
5Years -62.92%
7Years -39.76%
10Years -10.08%
EFFICIENCY
Earnings Waterfall Enzo Biochem, Inc.
image
Revenue 31.9 M
Cost Of Revenue 17.3 M
Gross Profit 14.6 M
Operating Expenses 27 M
Operating Income -9.82 M
Other Expenses 16.3 M
Net Income -26.1 M

Income Statement

Millions
Jul-2024 Jul-2023 Jul-2022 Jul-2021 Jul-2020 Jul-2019 Jul-2018 Jul-2017 Jul-2016 Jul-2015 Jul-2014 Jul-2013 Jul-2012 Jul-2011 Jul-2010 Jul-2009 Jul-2008 Jul-2007 Jul-2006 Jul-2005 Jul-2004 Jul-2003 Jul-2002 Jul-2001 Jul-2000 Jul-1999 Jul-1998 Jul-1997 Jul-1996 Jul-1995 Jul-1994 Jul-1993 Jul-1992 Jul-1991 Jul-1990 Jul-1989 Jul-1988 Jul-1987 Jul-1986
REVENUE
Revenue 31.9 31.1 107.1 117.7 76.0 81.2 104.7 107.8 102.8 97.6 95.9 93.7 103.1 102.0 97.1 89.6 77.8 52.9 39.8 43.4 41.6 52.8 54.0 58.4 50.0 44.3 40.4 34.9 34.5 31.7 22.8 20.0 20.5 19.8 19.4 12.1 9.1 8.7 7.3
GROSS PROFIT
Cost Of Revenue 17.3 19.5 65.1 64.2 52.3 57.9 60.4 59.5 57.2 54.8 54.3 54.8 56.0 53.8 52.1 53.1 40.2 23.2 16.1 14.7 13.1 11.8 10.8 17.4 14.1 14.3 13.8 13.8 13.6 12.1 9.3 6.7 6.2 21.2 5.2 3.6 1.9 1.7 1.4
Gross Profit 14.6 11.6 42.0 53.6 23.8 23.2 44.3 48.3 45.6 42.8 41.7 38.9 47.1 48.2 45.0 36.5 37.6 29.7 23.7 28.7 28.5 41.0 43.2 41.0 35.9 30.0 26.6 21.1 20.9 19.6 13.5 13.3 14.3 (1.4) 14.2 8.5 7.2 7.0 5.9
OPERATING INCOME
Operating Expenses 27.0 31.1 57.5 48.2 47.4 47.4 51.4 49.7 49.4 46.7 48.0 52.0 63.0 61.1 65.3 60.6 52.4 50.6 43.9 39.0 40.8 36.6 34.2 31.8 30.8 26.7 25.8 21.4 22.4 21.3 13.9 18.4 13.6 1.2 16.3 12.5 10.1 10.1 4.8
Selling, General and Administrative Expenses 21.7 27.2 53.7 44.9 43.0 44.3 44.5 44.0 43.6 41.1 41.8 43.7 51.7 48.9 52.1 45.5 43.7 41.2 36.0 30.5 32.7 28.3 28.0 25.7 23.5 20.4 19.9 16.0 17.5 17.1 10.6 16.9 12.9 0 15.8 12.2 9.6 9.6 4.5
Research and Development Expenses 2.6 3.9 3.8 3.3 4.4 3.2 3.2 2.9 3.5 3.4 3.1 3.9 6.3 7.8 9.7 9.2 8.6 9.4 7.9 8.5 8.1 8.3 6.2 6.1 5.4 4.4 4.0 3.6 3.1 2.4 1.8 0 0 0 0 0 0 0 0
Operating Income (9.8) (24.7) (15.5) 9.9 (23.6) 78.1 (12.2) (3.1) 47.0 (1.2) (10.2) (19.0) (40.5) (12.9) (22.1) (24.1) (14.8) (21.0) (20.2) (10.3) (12.2) 4.4 9.0 9.2 5.1 3.3 0.8 (0.3) (1.5) (1.7) (0.4) (5.1) 0.7 (2.6) (2.1) (4.0) (2.9) (3.1) 1.1
PRE-TAX INCOME
Interest Income Expense 0.2 0 0.2 0 0 0 9.8 2.6 0 0 7.1 11.5 50.0 0 3.9 0 0 (0.3) (3.1) (29.5) (1.2) (1.4) (1.4) (3.0) (2.6) (2.1) (3.7) (3.7) 12.0 (22.8) (5.3) 2.7 1.6 0 (0.4) (3.7) 0 (2.8) (3.1)
Total Other Income 0 (0.3) (3.3) 7.2 1.8 29.7 0.7 0.6 56.9 (1.1) 0.3 31 K (0.4) 0.1 (0.2) 70 K 3.9 7.8 3.1 15.5 1.2 1.4 1.4 3.0 2.6 2.1 1.8 1.9 (6.0) 11.4 2.6 (1.2) (1.8) 2.6 (1.8) 0 3.0 (0.5) 1.0
Pre-Tax Income (9.8) (25.0) (18.3) 7.9 (28.5) 2.5 (11.4) (2.4) 46.5 (2.3) (9.9) (18.9) (40.9) (12.8) (22.3) (23.5) (10.9) (13.2) (17.0) 5.2 (11.1) 5.7 10.3 12.2 7.7 5.4 2.6 1.6 (7.5) 9.7 2.2 (6.3) (1.1) (2.6) (3.9) (4.0) 100 K (3.6) 2.1
NET INCOME
Tax Provision 0 12.3 4.3 4.5 5.4 101.3 (1.1) 82 K 1.2 7 K 72 K (0.7) (1.7) 0.1 28 K 87 K (0.2) 85 K (1.3) 2.2 (4.8) 1.9 3.4 5.4 1.0 (1.1) (0.8) 100 K 0.2 4.1 (2.9) 100 K 100 K 12.9 0.2 100 K 0.6 (2.0) 0.6
Net Income (26.1) 20.3 (22.6) 3.4 (33.9) (98.8) (10.3) (2.5) 45.3 (2.3) (10.0) (18.2) (39.3) (13.0) (22.2) (23.6) (10.7) (13.3) (15.7) 3.0 (6.2) 3.8 6.9 6.8 6.6 6.5 3.4 1.5 (7.7) 5.6 5.3 (6.9) (0.6) (10.8) (4.1) (4.1) (3.5) (1.6) 1.5
EPS 0.51 1.27 0.46 0.0711 0.71 2.09 0.22 0.054 0.98 0.0504 0.23 0.46 1.01 0.34 0.59 0.63 0.29 0.38 0.49 0.09 0.2 0.11 0.22 0.22 0.22 0.21 0.12 0.0494 0.27 0.19 0.19 0.29 0.0329 0.71 0.26 0.27 0.24 0.11 0.0904